Molar mass 436.545 g/mol | ||
 | ||
Cipemastat (rINN, also known as Ro 32-3555 and by the tentative trade name Trocade) is a selective inhibitor of matrix metalloproteinase-1 that has been investigated as an anti-arthritis agent. It is being developed by Roche.
References
Cipemastat Wikipedia(Text) CC BY-SA